Pacific Biosciences Of California (PACB)
Cost of Revenue
$26.37M
Quarterly · Period ending: · USD
PACB Cost of Revenue
Latest reported$26.37Mperiod ending
Latest reported$26.37Mperiod ending
PACB Quarterly Cost of Revenue ($0.00 → $26.37M)
Quarterly cost of revenue
High-resolution chart · PNG
PACB cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 26,369,000 | |
| 24,337,000 | |
| 27,896,000 | |
| 23,373,000 | |
| 25,082,000 | |
| 38,524,000 | |
| 29,166,000 | |
| 29,963,000 | |
| 30,075,000 | |
| 27,528,000 | |
| 48,786,000 | |
| 37,789,000 | |
| 32,027,000 | |
| 29,139,000 | |
| 22,213,000 | |
| 18,764,000 | |
| 19,274,000 | |
| 19,018,000 | |
| 19,253,000 | |
| 19,523,000 | |
| 16,857,000 | |
| 16,020,000 | |
| 15,735,000 | |
| 12,018,000 | |
| 10,464,000 | |
| 8,110,000 | |
| 14,998,000 | |
| 15,001,000 | |
| 15,008,000 | |
| 11,308,000 | |
| 13,780,000 | |
| 14,968,000 | |
| 12,716,000 | |
| 12,066,000 | |
| 15,441,000 | |
| 15,318,000 | |
| 12,072,000 | |
| 15,978,000 | |
| 14,348,000 | |
| 12,480,000 | |
| 10,103,000 | |
| 9,623,000 | |
| 9,815,000 | |
| 7,366,000 | |
| 10,433,000 | |
| 11,718,000 | |
| 12,466,000 | |
| 7,461,000 | |
| 8,299,000 | |
| 8,966,000 | |
| 5,945,000 | |
| 6,180,000 | |
| 4,989,000 | |
| 4,648,000 | |
| 5,251,000 | |
| 2,586,000 | |
| 7,016,000 | |
| 10,190,000 | |
| 10,907,000 | |
| 7,191,000 | |
| 2,731,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |